What is your current role in EPAD? I am one of the leaders of Work package 2 as well as a steering committee member. Work package 2 is responsible for creation of the disease models and adaptive design platform trial. In addition, I contributed to the development of proof of concept protocol with work package…
What is your current role in EPAD? With Adrian Mander, I lead the Disease Modelling Workstream in WP2 (Statistical/Methodology Engine Room). Our principal task is to analyse, on an on-going basis, data arising from the EPAD Longitudinal Cohort Study and the EPAD Proof of Concept Trial in order to refine disease models across the EPAD…
The Alzheimer’s Association International Conference took place in Toronto from 23 to 28 July. EPAD – funded by the Innovative Medicines Initiative (IMI) – featured in a number of key symposia and communications: At a joint pre-conference meeting of the Global Alzheimer’s Platform and EPAD on global Alzheimer’s research collaboration on 22 July, EPAD researchers…
The European Prevention of Alzheimer’s Dementia initiative (EPAD) has recruited its first research participant in Spain, Maria (pictured). The EUR 64 million Europe-wide initiative, which aims to improve our understanding of the early stages of Alzheimer’s disease and how it leads to dementia, is building a registry of 24,000 people and a cohort of 6,000…
Partners from two of the most important research programmes in the dementia field – the European Prevention of Alzheimer’s Dementia (EPAD) initiative and the European Medical Information Framework (EMIF) – have published an article in the journal Lancet Psychiatry, titled “Better together for better dementia research and care” in the run up to the UK’s…
On 17-19 May, the EPAD project General Assembly took place in Barcelona, under the banner “Initiation and Delivery”. The first day began with project leaders Craig Ritchie, Serge van der Geyten and Jose Luis Molinuevo welcoming some 120 delegates to the meeting. The delegates then joined working sessions to discuss their progress toward the project…
The European Prevention of Alzheimer’s Dementia (EPAD) is an initiative that groups together 36 academic research centres & universities, biotech & pharmaceutical companies and patient associations with the aim of establishing an infrastructure to facilitate clinical trials to prevent the onset of the disease. The first volunteers, from Edinburgh and Barcelona, are currently being incorporated…
This is a unique opportunity for a future clinical academic neuroradiologist to gain research training experience while working on the neuroimaging data in the European Prevention of Alzheimer’s Dementia, EPAD research programme. http://ep-ad.org You will be based in a world-leading Academic Neuroradiology Department (under Professor Joanna Wardlaw), partnering with the Centre for Dementia Prevention (CDP)…
A major study to find interventions that prevent the onset of Alzheimer’s dementia has recruited its first participant. The £50 million (€64 m) Europe-wide initiative aims to improve understanding of the early stages of Alzheimer’s disease and how it leads to dementia. Julie (pictured) from near Edinburgh in Scotland is the first person to take…
The first quarter of 2016 started with great intensity! We were busy working towards recruiting the very first research participant into our study and should reach this important milestone early next month. A serious engagement of the entire EPAD family was also needed for the mandatory scientific and financial progress report to the Innovative…
